Generation Bio Ratios (2021-2025) | GBIO

Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -3,854.43%-1,461.18%-1,334.99%-1,836.44%-499.44%-202.71%-510.55%-279.28%-2,735.03%-346.30%
EBIT Margin -3,854.43%-1,461.18%-1,334.99%-1,912.64%-569.76%-236.75%-562.63%-313.32%-2,995.56%-420.83%
EBITDA Margin -3,536.70%-1,316.26%-1,212.93%-1,848.04%-501.47%-194.78%-514.37%-280.68%-2,745.62%-346.05%
Operating Margin -3,854.43%-1,461.18%-1,334.99%-1,912.64%-569.76%-236.75%-562.63%-313.32%-2,995.56%-420.83%
Net Margin -3,854.43%-1,461.18%-1,334.99%-1,836.44%-499.44%-202.71%-510.55%-279.28%-2,735.03%-346.30%
FCF Margin 2,653.86%-1,188.54%-1,027.03%-828.16%-526.74%-259.97%-385.91%-543.02%-2,236.99%-3,304.89%
Efficiency
Assets Average 502.44M477.41M470.40M460.40M431.51M410.90M389.53M403.84M418.15M393.19M378.12M330.32M275.57M257.02M239.99M216.27M190.39M150.66M
Equity Average 446.07M420.31M394.48M367.33M338.89M316.81M295.62M280.82M266.71M243.10M217.52M167.56M123.70M109.92M95.32M79.77M63.72M52.33M
Invested Capital 458.74M433.40M407.21M381.75M352.92M324.87M308.75M282.49M279.14M254.29M231.91M203.13M131.99M115.41M104.44M86.20M73.33M54.10M50.56M
Asset Utilization Ratio 0.000.010.020.030.050.070.080.100.090.08
Leverage & Solvency
Equity Ratio 0.890.880.880.800.790.780.770.750.650.630.610.540.460.440.420.370.360.300.41
Valuation
Enterprise Value -451.08M-425.19M-398.36M-375.14M-336.98M-312.20M-301.17M-279.09M-288.65M-314.14M-291.02M-264.36M-37.71M-216.94M-184.77M-185.22M-157.56M-141.36M-89.62M
Return Ratios
Return on Sales -38.54%-14.61%-13.35%-18.36%-4.99%-2.03%-5.11%-2.79%-27.35%-3.46%
Return on Capital Employed -0.37%-0.35%-0.37%-0.41%-0.60%-0.70%-0.69%-0.69%-0.41%-0.47%-0.54%
Return on Assets -0.09%-0.17%-0.27%-0.35%-0.33%-0.34%-0.37%-0.54%-0.60%-0.58%-0.55%-0.33%-0.38%-0.42%
Return on Equity -0.11%-0.22%-0.36%-0.50%-0.51%-0.55%-0.64%-1.06%-1.33%-1.35%-1.38%-0.90%-1.14%-1.20%